StudyFinder

Search Results Within Category "Cancer"

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

Search all categories

Suggestions within category "Cancer"

5 Study Matches

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Takeda Contact - medinfoUS@takeda.com

NCT06562543
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:

• Provide written (or electronic) informed consent.
• Male or female aged more than or equal to (≥)18 years.
• Presence of histologically and/or cytologically documented metastatic colorectal adenocarcinoma. Rat sarcoma virus (RAS) status for each participant must be documented.
• Have been previously treated with standard approved therapies: * Fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, * An anti-vascular endothelial growth factor (VEGF) biological therapy (e.g., bevacizumab, aflibercept, ramucirumab \[regorafenib is NOT an anti-VEGF biologic\]), and * If RAS wild-type and medically appropriate, an anti-epidermal growth factor receptor (EGFR) therapy (e.g., cetuximab, panitumumab). * If known microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) tumor and medically appropriate, a programmed cell death protein 1 (PD1) inhibitor.
• Self-identify as Black and/or African American or Hispanic and/or Latino or as both.
• Body weight ≥40 kilograms (kg).
• Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 at screening.
• Have assessable disease according to RECIST version 1.1, assessed locally.
• In participants of childbearing potential, agreement to use highly effective form(s) of contraception, which results in a low failure rate (less than \[\<\]1 percent \[%\] per year) when used consistently and correctly, starting during the screening period, continuing throughout the entire trial period, and for 2 weeks after taking the last dose of the trial intervention. Such methods include oral (PO) hormonal contraception (combined estrogen/progestogen or progestogen-only) associated with inhibition of ovulation, intrauterine device, intrauterine hormone-releasing system (IUS), bilateral tubal ligation, vasectomized partner, or true sexual abstinence in line with the preferred and usual lifestyle of the participant. Those assigned male sex at birth must always use a condom.
Exclusion Criteria:

• Absolute neutrophil count (ANC) \<1.5 times 10\^9 per liter (10\^9/L), platelet count \<100 times 10\^9/L, or hemoglobin \<9.0 grams per deciliter (g/dL). Blood transfusion within 1 week prior to enrollment for the purpose of increasing the likelihood of eligibility is not allowed.
• Serum total bilirubin more than (\>)1.5 times the upper limit of normal range (ULN). Participants with previously documented Gilbert syndrome and bilirubin \<2 times ULN are eligible.
• Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \>2.5 times ULN in participants without hepatic metastases; ALT or AST \>5 times ULN in participants with hepatic metastases.
• Creatinine clearance \<30 milliliters per minute (mL/min). Creatinine clearance can either be measured in a 24-hour urine collection or estimated by the Cockcroft-Gault equation. Where available and appropriate, other formulae may be used to estimate clearance after consultation with the trial medical monitor.
• Urine dipstick or urinalysis with protein ≥2 positive or 24-hour urine protein ≥1.0 gram per 24 hours (g/24 hours). Participants with 1+ positive proteinuria must undergo a 24-hour urine collection to assess urine protein level.
• Uncontrolled hypertension, defined as systolic BP ≥140 millimeter of mercury (mmHg) and/or diastolic blood pressure (BP) ≥90 mmHg despite optimal medical management. The participant must have BP below both limits. Repeated assessments are permitted.
• International normalized ratio (INR) \>1.5 times ULN or activated partial thromboplastin time (aPTT) \>1.5 times ULN, unless the participant is currently receiving or intended to receive anticoagulants for prophylactic purposes.
• History of or active gastric/duodenal ulcer or ulcerative colitis, active hemorrhage of an unresected gastrointestinal tumor, history of perforation or fistulas, or any other condition that could, in the investigator's judgment, result in gastrointestinal hemorrhage or perforation within the 6 months prior to screening.
• History or presence of hemorrhage from any other site (e.g, hemoptysis or hematemesis) within 2 months prior to screening.
• History of a thromboembolic event, including deep vein thrombosis, pulmonary embolism, or arterial embolism within 6 months prior to screening.
• Stroke and/or transient ischemic attack within 12 months prior to screening.
• Clinically significant cardiovascular disease, including but not limited to, acute myocardial infarction or coronary artery bypass surgery within 6 months prior to enrollment, severe or unstable angina pectoris, New York Heart Association Class III/IV congestive heart failure, ventricular arrhythmias requiring treatment, or left ventricular ejection fraction \<50% by echocardiogram.
• QT interval, corrected using the Fridericia method (QTcF) \>480 milliseconds or any factors that increase the risk of QT interval, corrected based on the patient's heart rate (QTc) prolongation or risk of arrhythmic events such as hypokalemia, congenital long QT syndrome, or family history of long QT syndrome.
• Systemic antineoplastic therapies (except for that described in exclusion criterion no. 15) or any investigational therapy within 2 weeks prior to the first dose of the trial intervention, including chemotherapy, radical radiotherapy, hormonotherapy, biotherapy, and immunotherapy.
• Systemic small molecule targeted therapies (e.g., tyrosine kinase inhibitors \[TKIs\]) within 5 half-lives or 4 weeks (whichever is shorter) prior to the first dose of the trial intervention.
• Palliative radiotherapy for bone metastasis/lesion within 2 weeks prior to the initiation of the trial intervention.
• Brachytherapy (i.e., implantation of radioactive seeds) within 60 days prior to the first dose of the trial intervention.
• Surgery or invasive procedure (i.e., a procedure that includes a biopsy; central venous catheter placement is allowed) within 14 days prior to the first dose of the trial intervention or unhealed surgical incision.
• Any unresolved toxicities from previous antitumor treatments greater than NCI CTCAE, version 5.0, Grade 1 (except for alopecia or neurotoxicity Grade less than or equal to \[≤\]2).
• Known human immunodeficiency virus infection.
• Known history of active viral hepatitis. For participants with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load had to be undetectable on suppressive therapy, if indicated. Participants with hepatitis C virus (HCV) infection who are currently on treatment are eligible if they have an undetectable HCV viral load.
• Clinically uncontrolled active infection requiring intravenous (IV) antibiotics.
• Tumor invasion of a large vascular structure (e.g., pulmonary artery or superior or inferior vena cava).
• Those who are currently pregnant or lactating.
• Brain metastases and/or spinal cord compression untreated with surgery and/or radiotherapy, and without clinical imaging evidence of SD for 14 days or longer; participants requiring steroids within 4 weeks prior to the start of the trial intervention are to be excluded.
• Other malignancy, except for non-melanoma skin cancer, in situ cervical carcinoma, or bladder carcinoma (tumor in situ and T1) that had been adequately treated during the 5 years prior to screening. Participants with another primary malignancy that has been adequately treated may be included after consultation with the trial medical monitor.
• Inability to take medication PO, dysphagia, or an active gastric ulcer resulting from previous surgery (e.g., gastric bypass) or a severe gastrointestinal disease, or any other condition that investigators believe might affect absorption of the investigational medicinal product (IMP).
• Other disease, metabolic disorder, physical examination anomaly, abnormal laboratory result, or any other condition (e.g., current alcohol or drug abuse) that investigators suspect might prohibit use of the IMP, affect interpretation of trial results, or put the participant at undue risk of harm based on the investigator's assessment.
• Known hypersensitivity to fruquintinib or any of its inactive ingredients, including the azo dyes Tartrazine- Federal Food, Drug, and Cosmetic Act (FD\&C) Yellow 5 and Sunset yellow For Coloring Food (FCF)-FD\&C Yellow 6.
• Received prior fruquintinib.
• Live vaccine ≤28 days before the first dose of the trial intervention. Seasonal vaccines for influenza are generally inactivated vaccines and are allowed. Intranasal vaccines are live vaccines and are not allowed.
• Use of strong inducers of cytochrome P450 3A4 (CYP3A4) within 2 weeks before the first dose of the trial intervention.
DRUG: Fruquintinib
Colorectal Cancer
colorectal cancer, fruquintinib
I'm interested
Share via email
Show 45 locations

Study Locations

Hide all locations
Location Contacts
Albert Einstein College of Medicine The Bronx, New York
BRCR Global Plantation, Florida
Baptist Health - Miami Cancer Institute Miami, Florida
Baylor College of Medicine Houston, Texas Site Contact - (karen.riggins@bcm.edu)
Boston Medical Center Boston, Massachusetts
Capital Health Medical Center - Hopewell Pennington, New Jersey Site Contact - (ALoaiza-Bonilla@capitalhealth.org)
Central Alabama Research Birmingham, Alabama Site Contact - (kashraf@centralalabamaresearch.com)
Christiana Care Health Services Newark, Delaware Site Contact - (jmisleh@cbg.org)
Columbia University New York, New York
Emory University Atlanta, Georgia Site Contact - (olatunji.alese@emory.edu)
Fox Chase Cancer Center | Philadelphia, PA Philadelphia, Pennsylvania
Fundacion de Investigacion de Diego (FDI Clinical Research) San Juan, Site Contact - (macosta@fdipr.com)
Hattiesburg Clinic Hattiesburg, Mississippi Site Contact - (bo.hrom@hattiesburgclinic.com)
Hightower Clinical Research Oklahoma City, Oklahoma Site Contact - (lam@hightowerclinical.com)
Hope and Healing Cancer Services Hinsdale, Illinois Site Contact - (sgundala@hopenheal.care)
Indiana University Indianapolis, Indiana Site Contact - (aalhader@iu.edu)
Ironwood Cancer and Research Centers Chandler, Arizona Site Contact - (dharia@ironwoodcrc.com)
James J Peters Veterans Administration Medical Center - NAVREF The Bronx, New York
Jefferson Health Philadelphia, Pennsylvania Site Contact - (Atrayee.BasuMallick@jefferson.edu)
Medical University of South Carolina Charleston, South Carolina
Medstar Speciality Hospital Northwest, Washington Site Contact - (marcus.s.noel@gunet.georgetown.edu)
Mercy Medical Center Durango, Colorado Site Contact - (pledakis@mdmercy.com)
Midwest Oncology Associates - Kansas City Kansas City, Missouri Site Contact - (jaswinder.singh@amrllc.com)
Oncology Consultants - Memorial City Location Houston, Texas Site Contact - (jpeguero@OncologyConsultants.com)
Our Lady of the Lake Physician Group - LSU Health Baton Rouge Oncology Baton Rouge, Louisiana Site Contact - (stagg.patrick@yahoo.com)
PIH Health Whittier Hospital Downey, California Site Contact - (Andrew.Pham@pihhealth.org)
Renovatio Clinical The Woodlands, Texas Site Contact - (mary.crow@renovatioclinical.com)
Renovatio Clinical The Woodlands, Texas Site Contact - (jonathan.lu@renovatioclinical.com)
SSM Health St. Louis DePaul Hospital St Louis, Missouri Site Contact - (brian.smith@ssmhealth.com)
Saint Luke's Cancer Institute Kansas City, Missouri
Tranquil Research Webster, Texas Site Contact - (drknecht@cls.health)
UC Irvine Medical Center - Chao Family Comprehensive Cancer Orange, Virginia Site Contact - (fdayyani@uci.edu)
University of Alabama at Birmingham Birmingham, Alabama Site Contact - (ggupta@uabmc.edu)
University of Arizona Tucson, Arizona Site Contact - (ajscott@arizona.edu)
University of California San Diego San Diego, California Site Contact - (gbotta@ucsd.edu)
University of Florida Gainesville, Florida Site Contact - (thomas.george@medicine.ufl.edu)
University of Miami Miami, Florida
University of Southern California Los Angeles, California Site Contact - (algaze@usc.edu)
University of Tennessee -- Memphis Memphis, Tennessee Site Contact - (schokshi@uthsc.edu)
University of Texas Southwestern Medical Center Dallas, Texas Site Contact - (Nilesh.Verma@UTSouthwestern.edu)
Vanderbilt University Medical Center Nashville, Tennessee Site Contact - (brooke.d.looney@vumc.org)
Virginia Commonwealth University Richmond, Virginia Site Contact - (khalid.matin@vcuhealth.org)
Washington University School of Medicine St Louis, Missouri Site Contact - (nikolaos@wustl.edu)
Willis Knighton Cancer Center Shreveport, Louisiana Site Contact - (jfeagin@wkhs.com)
Zangmeister Cancer Center Columbus, Ohio Site Contact - (smikhail@zangcenter.com)

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Massey IIT Research Operations - masseyepd@vcu.edu

NCT06728072
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Diagnosis of stage IV colorectal cancer * Measurable disease by Response evaluation criteria in solid tumors (RECIST) 1.1 criteria * Planned first-line treatment with a 5FU-based doublet chemotherapy regimen for colon cancer, specifics of the regimen at the discretion of the treating physician Note: Patients who have received adjuvant therapy \>6 months prior are eligible * Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2 * Absolute neutrophil count (ANC) ≥1,500 cells/μL * Platelet count ≥100,000 cells/μL * Hemoglobin ≥8 g/dL Note: The use of transfusion or other intervention to achieve hemoglobin ≥8 g/dL is acceptable. * Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤2.5 × upper limit of normal (ULN) Note: Patients with documented liver metastases: AST and ALT ≤5 × ULN * Serum creatinine ≤1.5 x ULN or calculated creatinine clearance ≥40 mL/min using the Cockcroft-Gault equation: (140 - age) × body weight/plasma creatinine × 72 (× 0.85 if female) * Radiographically measurable disease by RECIST 1.1 * Nonpregnant and not actively breastfeeding * Sexually active patients of childbearing potential and their partners must agree to use medically acceptable form of contraception, per treating investigator, throughout the study Patients should continue to use medically acceptable methods of contraception after study treatment ends, following the guidance for their specific chemotherapy regimen. Childbearing potential excludes: Age \> 50 years and naturally amenorrhoeic for \> 1 year OR previous hysterectomy or bilateral salpingo-oophorectomy
Exclusion Criteria:
* ongoing full dose anticoagulation Note: Patients on full dose anticoagulation may be approached to discuss study participation if lowering anticoagulation dose is feasible per the discretion of the treating investigator. Patients will be required to lower the anticoagulation dose by half 48 hours before beginning study drugs * Total colectomy * Diagnosed with Cockayne Syndrome * Using disulfiram, tizanidine, or theophylline and unable to stop taking these medications for the length of the microbiome modulation therapy * On methotrexate doses of 15 mg/week or more * History of allergic reaction to ciprofloxacin, metronidazole, or aspirin * Antibiotic use in the 30 days before chemotherapy start Note: Use of antibiotics intended for prophylaxis at the time of surgery is allowed * Corrected QT interval (QTc) \>480 on baseline ECG * Clinically significant hematuria, hematemesis, or hemoptysis of \>0.5 teaspoon (2.5 mL) of red blood, or other history of significant bleeding (eg, pulmonary hemorrhage) within 12 weeks before first dose of microbiome modulation therapy (significance determined by treating investigator) * Diagnosed with a malabsorptive syndrome * Inability to swallow tablets
DRUG: Standard of Care Chemotherapy + Metronidazole, ciprofloxacin, aspirin
Colorectal Cancer, CRC
Colorectal Cancer, CRC
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
Virginia Commonwealth University Richmond, Virginia Massey CTO GI Team - (masseygi@vcu.edu)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics (COSMIC)

Karen Craver - NCORP@wfusm.edu

NCT06418204
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Adults aged 18 years or older with one of the following newly diagnosed cancers: breast cancer, colorectal cancer, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer (e.g. adenocarcinoma, squamous cell carcinoma, large cell carcinoma, adenosquamous cell carcinoma, and not otherwise specified). * Planned treatment with systemic chemotherapy (single or multi-agent, includes targeted therapy) and/or immune checkpoint inhibitor therapy (targeting PD-1, PD-L1 or CTLA-4). If unable to engage participant before treatment starts, enrollment is allowed up to the start of Cycle 2 treatment. * Participants must be able to comprehend English or Spanish (for survey completion). * Participants must have a working email address and be must be willing to complete surveys online. This can be completed at home, in the clinic or other location. * Completion of the confidential Self-Reported Screening Survey and receipt of a screening result - eligible for enrollment. * Participant must reside in the United States, officially determined per patient report on Self-reported Screening Survey * In the treating provider's opinion, the participant should have a life expectancy of \>=6 months. Participants in hospice are not eligible. Optional Sub-study (available at select sites only): * Must be willing to participate in both the main study and the sub-study at the Wake Forest University Comprehensive Cancer Center (WF CCC) and Virginia Commonwealth University (VCU). * Must be receiving treatment at the WF CCC and VCU. * Must be diagnosed with non-small cell lung cancer. * Must be planning to receive paclitaxel as part of their chemotherapy in conjunction with Immune Checkpoint Inhibitor (ICIs) PD-1, PD-L1 or CTLA-4.
Exclusion Criteria:
* Currently enrolled in an interventional supportive treatment trial to manage cancer symptoms. * Participants with known pregnancy. * Participant received systemic therapy treatment for prior cancer(s) including chemotherapy, immunotherapy, targeted therapy, and hormonal therapy. * Participants enrolled in hospice. Optional Substudy (available at select sites only): * Participants with chronic or ongoing steroid or immunomodulatory agents (i.e., prednisone, dexamethasone, etanercept, infliximab, etc.). The use of glucocorticoids as pre-medications for chemotherapy treatment is allowed. * Participants with a history of HIV, hepatitis B or hepatitis C.
OTHER: Non-interventional Study
Breast Carcinoma, Colorectal Carcinoma, Lung Non-Small Cell Carcinoma, Melanoma, Non-Hodgkin Lymphoma
I'm interested
Share via email
Show 447 locations

Study Locations

Hide all locations
Location Contacts
AMG Crystal Lake - Oncology Crystal Lake, Illinois - (advocateresearch@advocate.com)
AMG Libertyville - Oncology Libertyville, Illinois - (advocateresearch@advocatehealth.com)
Abbott-Northwestern Hospital Minneapolis, Minnesota - (mmcorc@healthpartners.com)
Adams Cancer Center Gettysburg, Pennsylvania
Advocate Christ Medical Center Oak Lawn, Illinois
Advocate Good Samaritan Hospital Downers Grove, Illinois - (Barbara.barhamand@advocatehealth.com)
Advocate Good Shepherd Hospital Barrington, Illinois
Advocate High Tech Medical Park Palos Heights, Illinois - (ncorp@aah.org)
Advocate Illinois Masonic Medical Center Chicago, Illinois
Advocate Lutheran General Hospital Park Ridge, Illinois
Advocate Outpatient Center - Aurora Aurora, Illinois - (ncorp@aah.org)
Advocate Outpatient Center - Oak Lawn Oak Lawn, Illinois - (ncorp@aah.org)
Advocate Sherman Hospital Elgin, Illinois
Advocate South Suburban Hospital Hazel Crest, Illinois
AnMed Health Cancer Center Anderson, South Carolina - (rhonda.ballew@anmedhealth.org)
Armes Family Cancer Center Findlay, Ohio - (clinical.trials@daytonncorp.org)
Ascension All Saints Hospital Racine, Wisconsin - (AWRI.Inquiry@Ascension.org)
Ascension Calumet Hospital Chilton, Wisconsin - (AWRI.inquiry@ascension.org)
Ascension Columbia Saint Mary's Hospital - Milwaukee Milwaukee, Wisconsin - (AWRI.Inquiry@Ascension.org)
Ascension Columbia Saint Mary's Hospital Ozaukee Mequon, Wisconsin - (AWRI.Inquiry@Ascension.org)
Ascension Medical Group Southeast Wisconsin - Mayfair Road Wauwatosa, Wisconsin - (AWRI.Inquiry@Ascension.org)
Ascension Mercy Hospital Oshkosh, Wisconsin - (AWRI.inquiry@ascension.org)
Ascension Saint Elizabeth Hospital Appleton, Wisconsin - (AWRI.inquiry@ascension.org)
Ascension Saint Francis - Reiman Cancer Center Franklin, Wisconsin - (AWRI.Inquiry@Ascension.org)
Ascension Southeast Wisconsin Hospital - Elmbrook Campus Brookfield, Wisconsin - (AWRI.Inquiry@Ascension.org)
Aspirus Cancer Care - James Beck Cancer Center Rhinelander, Wisconsin - (Beth.Knetter@aspirus.org)
Aspirus Cancer Care - Stevens Point Stevens Point, Wisconsin - (Beth.Knetter@aspirus.org)
Aspirus Cancer Care - Wisconsin Rapids Wisconsin Rapids, Wisconsin
Aspirus Langlade Hospital Antigo, Wisconsin - (Juli.Alford@aspirus.org)
Aspirus Medford Hospital Medford, Wisconsin - (Beth.Knetter@aspirus.org)
Aspirus Regional Cancer Center Wausau, Wisconsin
Atrium Health Cabarrus/LCI-Concord Concord, North Carolina
Atrium Health Cleveland/LCI-Cleveland Shelby, North Carolina
Atrium Health Navicent Macon, Georgia - (andrew.weatherall@atriumhealth.org)
Atrium Health Pineville/LCI-Pineville Charlotte, North Carolina
Atrium Health Stanly/LCI-Albemarle Albemarle, North Carolina
Atrium Health Union/LCI-Union Monroe, North Carolina
Atrium Health University City/LCI-University Charlotte, North Carolina
Augusta Health Center for Cancer and Blood Disorders Fishersville, Virginia
Aurora Bay Area Medical Group-Marinette Marinette, Wisconsin - (ncorp@aurora.org)
Aurora BayCare Medical Center Green Bay, Wisconsin - (ncorp@aurora.org)
Aurora Cancer Care-Grafton Grafton, Wisconsin - (ncorp@aurora.org)
Aurora Cancer Care-Kenosha South Kenosha, Wisconsin - (ncorp@aurora.org)
Aurora Cancer Care-Milwaukee Milwaukee, Wisconsin - (ncorp@aurora.org)
Aurora Cancer Care-Milwaukee West Wauwatosa, Wisconsin - (ncorp@aurora.org)
Aurora Cancer Care-Racine Racine, Wisconsin - (ncorp@aurora.org)
Aurora Cancer Care-Southern Lakes VLCC Burlington, Wisconsin - (ncorp@aurora.org)
Aurora Health Care Germantown Health Center Germantown, Wisconsin - (ncorp@aurora.org)
Aurora Medical Center in Summit Summit, Wisconsin - (ncorp@aurora.org)
Aurora Saint Luke's Medical Center Milwaukee, Wisconsin - (ncorp@aurora.org)
Aurora Saint Luke's South Shore Cudahy, Wisconsin - (ncorp@aurora.org)
Aurora Sinai Medical Center Milwaukee, Wisconsin - (ncorp@aurora.org)
Aurora West Allis Medical Center West Allis, Wisconsin - (ncorp@aurora.org)
BJC Outpatient Center at Sunset Hills Sunset Hills, Missouri
Baptist Cancer Center-Grenada Grenada, Mississippi - (BCCclintrials@bmhcc.org)
Baptist Memorial Hospital and Cancer Center-Collierville Collierville, Tennessee - (BCCclintrials@bmhcc.org)
Baptist Memorial Hospital and Cancer Center-Desoto Southhaven, Mississippi - (BCCclintrials@bmhcc.org)
Baptist Memorial Hospital and Cancer Center-Golden Triangle Columbus, Mississippi - (BCCclintrials@bmhcc.org)
Baptist Memorial Hospital and Cancer Center-Memphis Memphis, Tennessee - (BCCclintrials@bmhcc.org)
Baptist Memorial Hospital and Cancer Center-Oxford Oxford, Mississippi - (BCCclintrials@bmhcc.org)
Baptist Memorial Hospital and Cancer Center-Union County New Albany, Mississippi - (BCCclintrials@bmhcc.org)
Baptist Memorial Hospital for Women Memphis, Tennessee - (BCCclintrials@bmhcc.org)
Beaufort Memorial Hospital Beaufort, South Carolina - (kwade@bmhsc.org)
Beebe Health Campus Rehoboth Beach, Delaware - (research@beebehealthcare.org)
Beebe South Coastal Health Campus Millville, Delaware - (research@beebehealthcare.org)
Benefis Sletten Cancer Institute Great Falls, Montana - (mccinfo@mtcancer.org)
Billings Clinic Cancer Center Billings, Montana - (research@billingsclinic.org)
Blanchard Valley Hospital Findlay, Ohio - (clinical.trials@daytonncorp.org)
Bozeman Health Deaconess Hospital Bozeman, Montana - (mccinfo@mtcancer.org)
Broadlawns Medical Center Des Moines, Iowa
Bronson Battle Creek Battle Creek, Michigan - (crcwm-regulatory@crcwm.org)
CHI Health Good Samaritan Kearney, Nebraska - (ResearchInstituteInquiries@CommonSpirit.org)
Cancer Care Center of O'Fallon O'Fallon, Illinois - (morganthaler.jodi@mhsil.com)
Cancer Care Specialists of Illinois - Decatur Decatur, Illinois - (morganthaler.jodi@mhsil.com)
Cancer Center at Saint Joseph's Phoenix, Arizona - (ResearchInstituteInquiries@CommonSpirit.org)
Cancer Hematology Centers - Flint Flint, Michigan - (wstrong@ghci.org)
Cancer and Hematology Centers of Western Michigan - Norton Shores Norton Shores, Michigan
Carilion Roanoke Memorial Hospital Roanoke, Virginia
Carle Cancer Center Urbana, Illinois - (Research@carle.com)
Carle Cancer Institute Normal Normal, Illinois - (Research@Carle.com)
Carle Physician Group-Effingham Effingham, Illinois - (Research@carle.com)
Carle Physician Group-Mattoon/Charleston Mattoon, Illinois - (Research@carle.com)
Carle at The Riverfront Danville, Illinois - (Research@Carle.com)
CaroMont Health - Lincoln Cancer Center Lincolnton, North Carolina
CaroMont Regional Medical Center Gastonia, North Carolina - (tammy.cozad@caromonthealth.org)
Carolinas Medical Center/Levine Cancer Institute Charlotte, North Carolina
Centra Alan B Pearson Regional Cancer Center Lynchburg, Virginia - (Kevin.Patel@centrahealth.com)
CentraState Medical Center Freehold, New Jersey
Centralia Oncology Clinic Centralia, Illinois - (morganthaler.jodi@mhsil.com)
Chilton Medical Center Pompton, New Jersey
Christiana Care - Union Hospital Elkton, Maryland - (frank.crum@christianacare.org)
Coborn Cancer Center at Saint Cloud Hospital Saint Cloud, Minnesota - (coborncancercenter@centracare.com)
Colorado Blood Cancer Institute Denver, Colorado - (info@westernstatesncorp.org)
Community Hospital of Anaconda Anaconda, Montana - (mccinfo@mtcancer.org)
Community Medical Center Missoula, Montana - (mccinfo@mtcancer.org)
Community Medical Center Missoula, Montana - (HemonCCTrials@geisinger.edu)
Condell Memorial Hospital Libertyville, Illinois - (advocateresearch@advocatehealth.com)
Contra Costa Regional Medical Center Martinez, California
Contra Costa Regional Medical Center Martinez, California
Corewell Health Grand Rapids Hospitals - Butterworth Hospital Grand Rapids, Michigan - (crcwm-regulatory@crcwm.org)
Corewell Health Reed City Hospital Reed City, Michigan - (crcwm-regulatory@crcwm.org)
Cotton O'Neil Cancer Center / Stormont Vail Health Topeka, Kansas
Cox Health South Hospital Springfield, Missouri
CoxHealth South Hospital Springfield, Missouri
Crossroads Cancer Center Effingham, Illinois - (morganthaler.jodi@mhsil.com)
Dayton Physician LLC - Englewood Dayton, Ohio - (clinical.trials@daytonncorp.org)
Dayton Physicians LLC-Atrium Franklin, Ohio - (clinical.trials@daytonncorp.org)
Decatur Memorial Hospital Decatur, Illinois - (morganthaler.jodi@mhsil.com)
Duluth Clinic Ashland Ashland, Wisconsin - (CancerTrials@EssentiaHealth.org)
Edwards Comprehensive Cancer Center Huntington, West Virginia - (Christina.Cole@chhi.org)
Englewood Hospital and Medical Center Englewood, New Jersey
Ephrata Cancer Center Ephrata, Pennsylvania
Essentia Health - Deer River Clinic Deer River, Minnesota - (CancerTrials@EssentiaHealth.org)
Essentia Health - Fosston Fosston, Minnesota - (CancerTrials@EssentiaHealth.org)
Essentia Health - Park Rapids Park Rapids, Minnesota - (CancerTrials@EssentiaHealth.org)
Essentia Health Cancer Center Duluth, Minnesota - (CancerTrials@EssentiaHealth.org)
Essentia Health Cancer Center-South University Clinic Fargo, North Dakota - (CancerTrials@EssentiaHealth.org)
Essentia Health Hibbing Clinic Hibbing, Minnesota
Essentia Health Saint Joseph's Medical Center Brainerd, Minnesota - (CancerTrials@EssentiaHealth.org)
Essentia Health Saint Mary's - Detroit Lakes Clinic Detroit Lakes, Minnesota - (CancerTrials@EssentiaHealth.org)
Essentia Health Sandstone Sandstone, Minnesota - (CancerTrials@EssentiaHealth.org)
Essentia Health Virginia Clinic Virginia, Minnesota - (CancerTrials@EssentiaHealth.org)
Fairbanks Memorial Hospital Fairbanks, Alaska - (Veronica.Stevenson@foundationhealth.org)
Fairview Northland Medical Center Princeton, Minnesota - (mmcorc@healthpartners.com)
Fairview Southdale Hospital Edina, Minnesota - (mmcorc@healthpartners.com)
Flaget Memorial Hospital Bardstown, Kentucky - (ResearchInstituteInquiries@CommonSpirit.org)
Geisinger Cancer Center Dickson City Dickson City, Pennsylvania - (hemoncctrials@geisinger.edu)
Geisinger Cancer Services-Pottsville Pottsville, Pennsylvania - (HemonCCTrials@geisinger.edu)
Geisinger Medical Center Danville, Pennsylvania - (HemonCCTrials@geisinger.edu)
Geisinger Medical Center-Cancer Center Hazleton Hazleton, Pennsylvania - (HemonCCTrials@geisinger.edu)
Geisinger Medical Oncology-Lewisburg Lewisburg, Pennsylvania - (HemonCCTrials@geisinger.edu)
Geisinger Wyoming Valley/Henry Cancer Center Wilkes-Barre, Pennsylvania - (HemonCCTrials@geisinger.edu)
Genesee Hematology Oncology PC Flint, Michigan - (wstrong@ghci.org)
Gibbs Cancer Center-Gaffney Gaffney, South Carolina - (kmertz-rivera@gibbscc.org)
Gibbs Cancer Center-Pelham Greer, South Carolina - (kmertz-rivera@gibbscc.org)
Glens Falls Hospital Glens Falls, New York Misty J DeCaro - (lacrosmj@glensfallshosp.org)
Greater Dayton Cancer Center Kettering, Ohio - (clinical.trials@daytonncorp.org)
Gundersen Lutheran Medical Center La Crosse, Wisconsin - (cancerctr@gundersenhealth.org)
HSHS Saint Elizabeth's Hospital O'Fallon, Illinois - (morganthaler.jodi@mhsil.com)
Hackettstown Medical Center Hackettstown, New Jersey
Harold Alfond Center for Cancer Care Augusta, Maine
Hawaii Cancer Care - Westridge ‘Aiea, Hawaii - (info@hawaiicancercare.com)
Hawaii Cancer Care Inc - Waterfront Plaza Honolulu, Hawaii - (i.webster@hawaiicancercare.com)
HaysMed Hays, Kansas
Hayworth Cancer Center High Point, North Carolina
Heartland Regional Medical Center Saint Joseph, Missouri - (Trisha.England2@mymlc.com)
Helen F Graham Cancer Center Newark, Delaware - (lbarone@christianacare.org)
Hematology Oncology Associates of Fredericksburg Inc Fredericksburg, Virginia - (cvaughn@hoafredericksburg.com)
Hennepin County Medical Center Minneapolis, Minnesota - (mmcorc@healthpartners.com)
Hi-Line Sletten Cancer Center Havre, Montana - (mccinfo@mtcancer.org)
Holy Name Hospital Teaneck, New Jersey
Illinois CancerCare - Washington Washington, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Bloomington Bloomington, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Canton Canton, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Carthage Carthage, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Dixon Dixon, Illinois
Illinois CancerCare-Eureka Eureka, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Galesburg Galesburg, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Kewanee Clinic Kewanee, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Macomb Macomb, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Ottawa Clinic Ottawa, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Pekin Pekin, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peoria Peoria, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peru Peru, Illinois - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Princeton Princeton, Illinois - (andersonj@illinoiscancercare.com)
Indu and Raj Soin Medical Center Beavercreek, Ohio - (clinical.trials@daytonncorp.org)
Iowa Methodist Medical Center Des Moines, Iowa
Jefferson Healthcare Port Townsend, Washington
Kadlec Clinic Hematology and Oncology Kennewick, Washington - (research@kadlecmed.org)
Kaiser Permanente Bellevue Medical Center Bellevue, Washington - (KPWAoncologytrials@kp.org)
Kaiser Permanente Downtown Commons Sacramento, California - (kpoct@kp.org)
Kaiser Permanente Dublin Dublin, California
Kaiser Permanente Fresno Orchard Plaza Fresno, California
Kaiser Permanente Medical Center - Santa Clara Santa Clara, California - (Kpoct@kp.org)
Kaiser Permanente Medical Center-Vacaville Vacaville, California - (Kpoct@kp.org)
Kaiser Permanente Moanalua Medical Center Honolulu, Hawaii - (shelley.a.clark@kp.org)
Kaiser Permanente Northwest Portland, Oregon - (information@kpchr.org)
Kaiser Permanente San Leandro San Leandro, California - (Kpoct@kp.org)
Kaiser Permanente Washington Seattle, Washington - (KPWAoncologytrials@kp.org)
Kaiser Permanente- Marshall Medical Offices Redwood City, California
Kaiser Permanente-Deer Valley Medical Center Antioch, California - (Kpoct@kp.org)
Kaiser Permanente-Franklin Denver, Colorado - (kristi.m.bronkan@kp.org)
Kaiser Permanente-Fremont Fremont, California - (Kpoct@kp.org)
Kaiser Permanente-Fresno Fresno, California - (Kpoct@kp.org)
Kaiser Permanente-Lone Tree Lone Tree, Colorado - (kristi.m.bronkan@kp.org)
Kaiser Permanente-Modesto Modesto, California - (Kpoct@kp.org)
Kaiser Permanente-Oakland Oakland, California - (Kpoct@kp.org)
Kaiser Permanente-Richmond Richmond, California - (Kpoct@kp.org)
Kaiser Permanente-Rock Creek Lafayette, Colorado - (kristi.m.bronkan@kp.org)
Kaiser Permanente-Roseville Roseville, California - (Kpoct@kp.org)
Kaiser Permanente-San Francisco San Francisco, California - (Kpoct@kp.org)
Kaiser Permanente-Santa Rosa Santa Rosa, California - (Kpoct@kp.org)
Kaiser Permanente-Santa Teresa-San Jose San Jose, California - (Kpoct@kp.org)
Kaiser Permanente-South Sacramento Sacramento, California - (Kpoct@kp.org)
Kaiser Permanente-South San Francisco South San Francisco, California - (Kpoct@kp.org)
Kaiser Permanente-Stockton Stockton, California - (Kpoct@kp.org)
Kaiser Permanente-Vallejo Vallejo, California - (Kpoct@kp.org)
Kaiser Permanente-Walnut Creek Walnut Creek, California - (Kpoct@kp.org)
Kaiser San Rafael-Gallinas San Rafael, California - (Kpoct@kp.org)
Kapiolani Medical Center for Women and Children Honolulu, Hawaii
Kettering Medical Center Kettering, Ohio - (clinical.trials@daytonncorp.org)
Kettering Medical Center Kettering, Ohio - (clinical.trials@daytonncorp.org)
Kingman Regional Medical Center Kingman, Arizona - (research@sncrf.org)
Kootenai Clinic Cancer Services - Post Falls Post Falls, Idaho - (mccinfo@mtcancer.org)
Kootenai Clinic Cancer Services - Sandpoint Sandpoint, Idaho - (mccinfo@mtcancer.org)
Kootenai Health - Coeur d'Alene Coeur d'Alene, Idaho - (mccinfo@mtcancer.org)
Lake Regional Hospital Osage Beach, Missouri - (clinicaltrials@lakeregional.com)
Lakeview Hospital Stillwater, Minnesota - (mmcorc@healthpartners.com)
Lawrence Memorial Hospital Lawrence, Kansas - (Stephanie.Norris@LMH.ORG)
Lehigh Valley Hospital - Muhlenberg Bethlehem, Pennsylvania - (Morgan_M.Horton@lvhn.org)
Lehigh Valley Hospital-Cedar Crest Allentown, Pennsylvania - (Morgan_M.Horton@lvhn.org)
Lehigh Valley Hospital-Hazleton Hazleton, Pennsylvania - (Morgan_M.Horton@lvhn.org)
Levine Cancer Institute - Huntersville Huntersville, North Carolina
Levine Cancer Institute - Rutherford Forest City, North Carolina
Levine Cancer Institute - Union West Matthews, North Carolina
Levine Cancer Institute-Ballantyne Charlotte, North Carolina
Levine Cancer Institute-Gaston Gastonia, North Carolina
Levine Cancer Institute-Rock Hill Rock Hill, South Carolina
Levine Cancer Institute-SouthPark Charlotte, North Carolina
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia - (underberga@sjchs.org)
Liberty County Cancer Care Hinesville, Georgia - (Oncologyresearch@sjchs.org)
Licking Memorial Hospital Newark, Ohio - (Jeffh@columbusccop.org)
Logan Health Medical Center Kalispell, Montana - (mccinfo@mtcancer.org)
Lovelace Medical Center-Saint Joseph Square Albuquerque, New Mexico - (ZPollock@salud.unm.edu)
Lovelace Women's Hospital Albuquerque, New Mexico - (AYost@nmcca.org)
MaineHealth Cancer Care Center of York County Sanford, Maine
MaineHealth Cancer Care and IV Therapy - Brunswick Brunswick, Maine - (clinicalresearch@mainehealth.org)
MaineHealth Cancer Care and IV Therapy - Sanford Sanford, Maine - (clinicalresearch@mainehealth.org)
MaineHealth Cancer Care and IV Therapy - South Portland South Portland, Maine - (clinicalresearch@mainehealth.org)
MaineHealth Maine Medical Center - Biddeford Biddeford, Maine - (clinicalresearch@mainehealth.org)
MaineHealth Maine Medical Center- Scarborough Scarborough, Maine - (clinicalresearch@mainehealth.org)
MaineHealth Penobscot Bay Hospital Rockport, Maine - (clinicalresearch@mainehealth.org)
MaineHealth Waldo Hospital Belfast, Maine - (clinicalresearch@mainehealth.org)
Marshfield Clinic - Wisconsin Rapids Center Wisconsin Rapids, Wisconsin - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Clinic-Chippewa Center Chippewa Falls, Wisconsin - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Clinic-Wausau Center Wausau, Wisconsin - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Ladysmith Ladysmith, Wisconsin - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Minocqua Minocqua, Wisconsin - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Neillsville Neillsville, Wisconsin - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Weston Weston, Wisconsin - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center Dickinson Iron Mountain, Michigan - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-EC Cancer Center Eau Claire, Wisconsin - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Marshfield Marshfield, Wisconsin - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Rice Lake Rice Lake, Wisconsin - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-River Region at Stevens Point Stevens Point, Wisconsin - (oncology.clinical.trials@marshfieldresearch.org)
Mayo Clinic Rochester, Minnesota
Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota
Mayo Clinic Health System-Eau Claire Clinic Eau Claire, Wisconsin
Mayo Clinic Health System-Franciscan Healthcare La Crosse, Wisconsin
Mayo Clinic Health Systems-Mankato Mankato, Minnesota
Medical Oncology Hematology Consultants PA Newark, Delaware - (lbarone@christianacare.org)
Medical University of South Carolina Charleston, South Carolina - (hcc-clinical-trials@musc.edu)
Memorial Hospital Chattanooga, Tennessee - (Jeffh@columbusccop.org)
Memorial Medical Center-Las Cruces Las Cruces, New Mexico - (Deborah.Brown@LPNT.net)
Mercy Cancer Center - Carmichael Carmichael, California - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center - Elk Grove Elk Grove, California - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center - Rocklin Rocklin, California - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center - Sacramento Sacramento, California - (ResearchInstituteInquiries@CommonSpirit.org)
Mercy Cancer Center-West Lakes Clive, Iowa - (cancerresearch@mercydesmoines.org)
Mercy Health - Paducah Cancer Center Paducah, Kentucky - (BJWarner@mercy.com)
Mercy Hospital Coon Rapids, Minnesota - (mmcorc@healthpartners.com)
Mercy Hospital Fort Smith Fort Smith, Arkansas
Mercy Hospital Joplin Joplin, Missouri - (esmeralda.carrillo@mercy.net)
Mercy Hospital Oklahoma City Oklahoma City, Oklahoma
Mercy Hospital Saint Louis St Louis, Missouri
Mercy Hospital South St Louis, Missouri - (Danielle.Werle@mercy.net)
Mercy Hospital Springfield Springfield, Missouri
Mercy Medical Center - Des Moines Des Moines, Iowa - (cancerresearch@mercydesmoines.org)
Mercy Oncology and Hematology - Clayton-Clarkson Ballwin, Missouri
Mercy San Juan Medical Center Carmichael, California - (OncologyResearch@DignityHealth.org)
Mid Coast Hospital Brunswick, Maine - (elizabeth.mutina@mainehealth.org)
Minnesota Oncology - Burnsville Burnsville, Minnesota - (mmcorc@healthpartners.com)
Minnesota Oncology Hematology PA-Maplewood Maplewood, Minnesota - (mmcorc@healthpartners.com)
Minnesota Oncology Hematology PA-Woodbury Woodbury, Minnesota - (mmcorc@healthpartners.com)
Mission Hope Medical Oncology - Arroyo Grande Arroyo Grande, California - (ResearchInstituteInquiries@CommonSpirit.org)
Mission Hope Medical Oncology - Santa Maria Santa Maria, California - (ResearchInstituteInquiries@CommonSpirit.org)
Missouri Baptist Medical Center St Louis, Missouri
Missouri Baptist Sullivan Hospital Sullivan, Missouri
Missouri Baptist Sullivan Hospital Sullivan, Missouri
Montana Cancer Consortium NCORP Billings, Montana - (mccinfo@mtcancer.org)
Montefiore Medical Center - Moses Campus The Bronx, New York - (eskwak@montefiore.org)
Montefiore Medical Center-Einstein Campus The Bronx, New York - (eskwak@montefiore.org)
Monticello Cancer Center Monticello, Minnesota - (mmcorc@healthpartners.com)
Monument Health Rapid City Hospital Rapid City, South Dakota - (research@monument.health)
Morristown Medical Center Morristown, New Jersey
Morton Plant Hospital Clearwater, Florida
Munson Medical Center Traverse City, Michigan - (crcwm-regulatory@crcwm.org)
MyMichigan Medical Center Alpena Alpena, Michigan - (CVResearch@mymichigan.org)
MyMichigan Medical Center Gladwin Gladwin, Michigan - (CVResearch@mymichigan.org)
MyMichigan Medical Center Gratiot Alma, Michigan - (CVResearch@mymichigan.org)
MyMichigan Medical Center Midland Midland, Michigan - (CVResearch@mymichigan.org)
MyMichigan Medical Center Mount Pleasant Mount Pleasant, Michigan - (CVResearch@mymichigan.org)
MyMichigan Medical Center Saginaw Saginaw, Michigan - (MCRCwebsitecontactform@stjoeshealth.org)
MyMichigan Medical Center Tawas Tawas City, Michigan - (MCRCwebsitecontactform@stjoeshealth.org)
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas
New Ulm Medical Center New Ulm, Minnesota - (mmcorc@healthpartners.com)
Newton Medical Center Newton, New Jersey
North Memorial Medical Health Center Robbinsdale, Minnesota - (mmcorc@healthpartners.com)
Northside Hospital Atlanta, Georgia - (ClinicalTrials@northside.com)
Northside Hospital - Duluth Duluth, Georgia - (Clinical.trials@northside.com)
Northside Hospital - Gwinnett Lawrenceville, Georgia - (Clinical.trials@northside.com)
OSF Saint Anthony Medical Center Rockford, Illinois
OSF Saint Anthony's Health Center Alton, Illinois
OSF Saint Francis Hospital and Medical Group Escanaba, Michigan - (ewd_research_admin@hshs.org)
Oncology Associates at Mercy Medical Center Cedar Rapids, Iowa
OptumCare Cancer Care at Charleston Las Vegas, Nevada - (research@sncrf.org)
OptumCare Cancer Care at Seven Hills Henderson, Nevada - (research@sncrf.org)
Overlook Medical Center Summit, New Jersey
PCR Oncology Arroyo Grande, California - (research@sncrf.org)
Pacific Central Coast Health Center-San Luis Obispo San Luis Obispo, California - (ResearchInstituteInquiries@CommonSpirit.org)
Pali Momi Medical Center ‘Aiea, Hawaii
Park Nicollet Clinic - Saint Louis Park Saint Louis Park, Minnesota - (mmcorc@healthpartners.com)
Parkland Health Center - Farmington Farmington, Missouri
Penrose-Saint Francis Healthcare Colorado Springs, Colorado - (ResearchInstituteInquiries@CommonSpirit.org)
Physicians' Clinic of Iowa PC Cedar Rapids, Iowa
Pocono Medical Center East Stroudsburg, Pennsylvania - (Morgan_M.Horton@lvhn.org)
Presbyterian Kaseman Hospital Albuquerque, New Mexico - (WBurman@phs.org)
Presbyterian Rust Medical Center/Jorgensen Cancer Center Rio Rancho, New Mexico
Prisma Health Cancer Institute - Butternut Greenville, South Carolina
Prisma Health Cancer Institute - Easley Easley, South Carolina - (Kim.Williams3@prismahealth.org)
Prisma Health Cancer Institute - Eastside Greenville, South Carolina
Prisma Health Cancer Institute - Faris Greenville, South Carolina
Prisma Health Cancer Institute - Greer Greer, South Carolina
Prisma Health Cancer Institute - Seneca Seneca, South Carolina
Prisma Health Cancer Institute - Spartanburg Boiling Springs, South Carolina
Providence Medical Foundation - Santa Rosa Santa Rosa, California
Providence Saint Mary Regional Cancer Center Walla Walla, Washington - (Cheryl.Dodd@providence.org)
Queen's Cancer Center - Kuakini Honolulu, Hawaii
Queen's Cancer Center - POB I Honolulu, Hawaii
Queen's Medical Center Honolulu, Hawaii
Queens Hospital Center Jamaica, New York Linda Bulone - (buloneL@nychhc.org)
Regional Cancer Care - Jesup Jesup, Georgia - (Oncologyresearch@sjchs.org)
Regions Hospital Saint Paul, Minnesota - (mmcorc@healthpartners.com)
Reid Health Richmond, Indiana - (clinical.trials@daytonncorp.org)
Rice Memorial Hospital Willmar, Minnesota - (mmcorc@healthpartners.com)
Ridgeview Medical Center Waconia, Minnesota - (mmcorc@healthpartners.com)
Rocky Mountain Cancer Centers - Centennial Centennial, Colorado - (info@westernstatesncorp.org)
Rocky Mountain Cancer Centers-Aurora Aurora, Colorado - (info@westernstatesncorp.org)
Rocky Mountain Cancer Centers-Boulder Boulder, Colorado - (info@westernstatesncorp.org)
Rocky Mountain Cancer Centers-Littleton Littleton, Colorado - (info@westernstatesncorp.org)
Rocky Mountain Cancer Centers-Midtown Denver, Colorado - (info@westernstatesncorp.org)
Rocky Mountain Cancer Centers-Rose Denver, Colorado - (info@westernstatesncorp.org)
Rocky Mountain Cancer Centers-Sky Ridge Lone Tree, Colorado - (info@westernstatesncorp.org)
Rocky Mountain Cancer Centers-Thornton Thornton, Colorado - (info@westernstatesncorp.org)
Rush-Copley Healthcare Center Yorkville, Illinois - (Cancer.Research@rushcopley.com)
Rush-Copley Medical Center Aurora, Illinois - (Cancer.Research@rushcopley.com)
SMC Center for Hematology Oncology Union Union, South Carolina - (kmertz-rivera@gibbscc.org)
SSM Health Good Samaritan Mount Vernon, Illinois - (gayla.hall@ssmhealth.com)
Saint Agnes Medical Center Fresno, California - (medresearch@samc.com)
Saint Alphonsus Cancer Care Center-Baker City Baker City, Oregon - (mccinfo@mtcancer.org)
Saint Alphonsus Cancer Care Center-Boise Boise, Idaho - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Caldwell Caldwell, Idaho - (stephanie.couch@stjoeshealth.org)
Saint Alphonsus Cancer Care Center-Nampa Nampa, Idaho - (mccinfo@mtcancer.org)
Saint Alphonsus Cancer Care Center-Ontario Ontario, Oregon - (mccinfo@mtcancer.org)
Saint Anthony North Hospital Westminster, Colorado - (ResearchInstituteInquiries@CommonSpirit.org)
Saint Anthony's Hospital Cancer Care Center St. Petersburg, Florida - (Research.CTO@baycare.org)
Saint Elizabeth Youngstown Hospital Youngstown, Ohio - (clinical.trials@daytonncorp.org)
Saint Francis Cancer Center Greenville, South Carolina - (ResearchInstituteInquiries@CommonSpirit.org)
Saint Francis Cancer Center Greenville, South Carolina - (melissa_beckman@bshsi.org)
Saint Francis Hospital Greenville, South Carolina - (melissa_beckman@bshsi.org)
Saint Francis Regional Medical Center Shakopee, Minnesota - (mmcorc@healthpartners.com)
Saint John's Hospital - Healtheast Maplewood, Minnesota - (mmcorc@healthpartners.com)
Saint Joseph Hospital East Lexington, Kentucky - (ResearchInstituteInquiries@CommonSpirit.org)
Saint Joseph London London, Kentucky - (ResearchInstituteInquiries@CommonSpirit.org)
Saint Joseph Mount Sterling Mount Sterling, Kentucky - (ResearchInstituteInquiries@CommonSpirit.org)
Saint Joseph's Hospital/Children's Hospital-Tampa Tampa, Florida - (jennifer.manns@baycare.org)
Saint Joseph's Medical Center Stockton, California
Saint Joseph's/Candler - Bluffton Campus Bluffton, South Carolina - (underberga@sjchs.org)
Saint Louis Cancer and Breast Institute-Ballwin Ballwin, Missouri
Saint Luke's Hospital of Duluth Duluth, Minnesota - (kdean@slhduluth.com)
Saint Vincent Hospital Cancer Center Green Bay Green Bay, Wisconsin - (ewd_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Oconto Falls Oconto Falls, Wisconsin - (ewd_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Saint Mary's Green Bay, Wisconsin - (ewd_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Sheboygan Sheboygan, Wisconsin - (ewd_research_admin@hshs.org)
Saint Vincent Hospital Cancer Center at Sturgeon Bay Sturgeon Bay, Wisconsin - (ewd_research_admin@hshs.org)
Sainte Genevieve County Memorial Hospital Sainte Genevieve, Missouri
Salina Regional Health Center Salina, Kansas - (mleepers@srhc.com)
Sechler Family Cancer Center Lebanon, Pennsylvania - (doxenberg@wellspan.org)
Sheboygan Physicians Group Sheboygan, Wisconsin - (ewd_research_admin@hshs.org)
Shenandoah Oncology PC Winchester, Virginia - (William.Houck@usoncology.com)
Sinai Hospital of Baltimore Baltimore, Maryland - (pridgely@lifebridgehealth.org)
South Carolina Cancer Specialists PC Hilton Head Island, South Carolina - (underberga@sjchs.org)
South Florida Baptist Hospital Plant City, Florida - (Claudia.Quinones@baycare.org)
Southern Illinois University School of Medicine Springfield, Illinois
Spartanburg Medical Center Spartanburg, South Carolina - (kmertz-rivera@gibbscc.org)
Springfield Clinic Springfield, Illinois
Springfield Memorial Hospital Springfield, Illinois - (pallante.beth@mhsil.com)
Straub Benioff Medical Center Honolulu, Hawaii
Straub Pearlridge Clinic ‘Aiea, Hawaii
Strecker Cancer Center-Belpre Belpre, Ohio - (Jeffh@columbusccop.org)
Swedish Cancer Institute-Edmonds Edmonds, Washington - (PCRC-NCORP@Swedish.org)
Swedish Cancer Institute-Issaquah Issaquah, Washington - (PCRC-NCORP@Swedish.org)
Swedish Medical Center-First Hill Seattle, Washington - (PCRC-NCORP@Swedish.org)
The Queen's Medical Center - West Oahu ‘Ewa Beach, Hawaii - (rohta@queens.org)
The Radiation Oncology Center-Hilton Head/Bluffton Hilton Head Island, South Carolina - (underberga@sjchs.org)
The University of Kansas Cancer Center - Olathe Olathe, Kansas - (OlatheCCResearch@kumc.edu)
ThedaCare Cancer Care - Berlin Berlin, Wisconsin - (ResearchDept@thedacare.org)
ThedaCare Cancer Care - New London New London, Wisconsin - (ResearchDept@thedacare.org)
ThedaCare Cancer Care - Oshkosh Oshkosh, Wisconsin - (ResearchDept@thedacare.org)
ThedaCare Cancer Care - Shawano Shawano, Wisconsin - (ResearchDept@thedacare.org)
ThedaCare Cancer Care - Waupaca Waupaca, Wisconsin - (ResearchDept@thedacare.org)
ThedaCare Regional Cancer Center Appleton, Wisconsin - (ResearchDept@thedacare.org)
ThedaCare Regional Medical Center - Neenah Neenah, Wisconsin - (ResearchDept@thedacare.org)
Tidelands Georgetown Memorial Hospital Georgetown, South Carolina - (broe@tidelandshealth.org)
Trinity Health Grand Rapids Hospital Grand Rapids, Michigan - (crcwm-regulatory@crcwm.org)
Trinity Health Muskegon Hospital Muskegon, Michigan - (crcwm-regulatory@crcwm.org)
Trinity Health Saint Joseph Mercy Hospital Ann Arbor Ann Arbor, Michigan - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Joseph Mercy Oakland Hospital Pontiac, Michigan - (MCRCwebsitecontactform@stjoeshealth.org)
UI Health Care Mission Cancer and Blood - Ankeny Clinic Ankeny, Iowa
UI Health Care Mission Cancer and Blood - Des Moines Clinic Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Laurel Clinic Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Waukee Clinic Waukee, Iowa
UI Health Care Mission Cancer and Blood - West Des Moines Clinic Clive, Iowa
UM Baltimore Washington Medical Center/Tate Cancer Center Glen Burnie, Maryland
UM Saint Joseph Medical Center Towson, Maryland - (Jeanmarie.downing@umm.edu)
United Hospital Saint Paul, Minnesota - (mmcorc@healthpartners.com)
University Health Truman Medical Center Kansas City, Missouri
University of Iowa Healthcare Cancer Services Quad Cities Bettendorf, Iowa - (katherine-daprile@uiowa.edu)
University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa
University of Kansas Cancer Center - Lee's Summit Lee's Summit, Missouri - (KUCC_Navigation@kumc.edu)
University of Kansas Cancer Center - North Kansas City, Missouri - (KUCC_Navigation@kumc.edu)
University of Kansas Cancer Center-Overland Park Overland Park, Kansas - (KUCC_Navigation@kumc.edu)
University of Kansas Health System Saint Francis Campus Topeka, Kansas
University of Kansas Hospital-Indian Creek Campus Overland Park, Kansas - (KUCC_Navigation@kumc.edu)
University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas - (KUCC_Navigation@kumc.edu)
University of Maryland/Greenebaum Cancer Center Baltimore, Maryland
University of Michigan Health - West Wyoming, Michigan - (crcwm-regulatory@crcwm.org)
University of New Mexico Cancer Center Albuquerque, New Mexico - (HSC-ClinicalTrialInfo@salud.unm.edu)
University of Wisconsin Carbone Cancer Center - University Hospital Madison, Wisconsin - (clinicaltrials@cancer.wisc.edu)
VCU Community Memorial Health Center South Hill, Virginia - (nemer.elmouallem@vcuhealth.org)
VCU Massey Cancer Center at Stony Point Richmond, Virginia - (ctoclinops@vcu.edu)
Vince Lombardi Cancer Clinic - Oshkosh Oshkosh, Wisconsin - (ncorp@aurora.org)
Vince Lombardi Cancer Clinic-Sheboygan Sheboygan, Wisconsin - (ncorp@aurora.org)
Vince Lombardi Cancer Clinic-Two Rivers Two Rivers, Wisconsin - (ncorp@aurora.org)
Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia - (CTOclinops@vcu.edu)
Wake Forest NCORP Research Base Winston-Salem, North Carolina Glenn Lesser, MD - (ncorp@wakehealth.edu) Beth Reboussin, PhD - (ncorp@wakehealth.edu)
Wake Forest University Health Sciences Winston-Salem, North Carolina
Wake Forest University at Clemmons Clemmons, North Carolina
WellSpan Medical Oncology and Hematology Hanover, Pennsylvania
Wellspan Health - York Cancer Center York, Pennsylvania
West Michigan Cancer Center Kalamazoo, Michigan - (crcwm-regulatory@crcwm.org)
Westfields Hospital/Cancer Center of Western Wisconsin New Richmond, Wisconsin - (mmcorc@healthpartners.com)
Wilcox Memorial Hospital and Kauai Medical Clinic Lihue, Hawaii
William E Kahlert Regional Cancer Center/Sinai Hospital Westminster, Maryland
Winter Haven Hospital Winter Haven, Florida - (Research.CTO@baycare.org)
Woodland Cancer Care Center Michigan City, Indiana - (sally.arnett@franciscanalliance.org)
Woodland Memorial Hospital Woodland, California - (ResearchInstituteInquiries@CommonSpirit.org)

The Vanguard Study: Testing a New Way to Screen for Cancer

ctrrecruit@vcu.edu

NCT06995898
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Ages 45-75 years old * Agree to provide blood samples for possible MCD testing at enrollment and at 1 year following enrollment * Agree to allow collection of information from their medical records for study-related purposes * Understand and be able to complete informed consent and participant questionnaires in English, Spanish, or Arabic * Note: Eligibility for Spanish and Arabic languages are at the Hub's discretion
Exclusion Criteria:
* Solid malignant tumor or blood cancer diagnosis, with or without treatment, within the last 5 years * Note: Persons with a history of in situ cancers (e.g., ductal carcinoma in situ of the breast, cervical cancer in situ, atypical melanocytic hyperplasia or melanoma in situ) or nonmelanoma skin cancer are eligible * Ongoing cancer diagnostic work-up * Ongoing participation in another study of an investigational cancer screening test or technology * Currently breastfeeding or pregnant, or planning to become pregnant in the next year
PROCEDURE: Biospecimen Collection, DEVICE: Device Usage, OTHER: Electronic Health Record Review, PROCEDURE: Multi-Cancer Detection Test, PROCEDURE: Multi-Cancer Detection Test, OTHER: Questionnaire Administration
Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma, Esophageal Carcinoma, Gastric Carcinoma, Liver Carcinoma, Lung Carcinoma, Malignant Solid Neoplasm, Ovarian Carcinoma, Pancreatic Carcinoma, Prostate Carcinoma
I'm interested
Share via email
Show 34 locations

Study Locations

Hide all locations
Location Contacts
Cancer Care and Hematology-Fort Collins Fort Collins, Colorado Site Public Contact - (ctsucontact@westat.com)
Henry Ford Cancer Institute-Downriver Brownstown, Michigan Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Hospital Detroit, Michigan Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Macomb Hospital-Clinton Township Clinton Township, Michigan Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Medical Center Sterling Heights, Michigan Site Public Contact - (ctsucontact@westat.com)
Henry Ford Medical Center - Detroit Northwest Detroit, Michigan Site Public Contact - (kkeenan1@hfhs.org)
Henry Ford Medical Center - Livonia Livonia, Michigan Site Public Contact - (kkeenan1@hfhs.org)
Henry Ford Medical Center - Plymouth Plymouth, Michigan Site Public Contact - (kkeenan1@hfhs.org)
Henry Ford Medical Center - Royal Oak Royal Oak, Michigan Site Public Contact - (kkeenan1@hfhs.org)
Henry Ford Medical Center - Troy Troy, Michigan Site Public Contact - (kkeenan1@hfhs.org)
Henry Ford Medical Center-Columbus Novi, Michigan Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Medical Center-Cottage Grosse Pointe Farms, Michigan
Henry Ford Medical Center-Fairlane Dearborn, Michigan Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford West Bloomfield Hospital West Bloomfield, Michigan Site Public Contact - (CTOResearch@hfhs.org)
Henry Ford Wyandotte Hospital Wyandotte, Michigan Site Public Contact - (nhay@hfhs.org)
Inova Fair Oaks Hospital Fairfax, Virginia Site Public Contact - (Stephanie.VanBebber@inova.org)
Inova Schar Cancer Institute Fairfax, Virginia Site Public Contact - (Stephanie.VanBebber@inova.org)
Kaiser Permanente Moanalua Medical Center Honolulu, Hawaii Site Public Contact - (shelley.a.clark@kp.org)
Kaiser Permanente-Division of Research Pleasanton, California
Kaiser Permanente-Franklin Denver, Colorado Site Public Contact - (kristi.m.bronkan@kp.org)
Kaiser Permanente-Lone Tree Lone Tree, Colorado Site Public Contact - (kristi.m.bronkan@kp.org)
Kaiser Permanente-Rock Creek Lafayette, Colorado Site Public Contact - (kristi.m.bronkan@kp.org)
Keefe Memorial Hospital Cheyenne Wells, Colorado Site Public Contact - (cmillsap@keefemh.org)
Medical Center of the Rockies Loveland, Colorado
Poudre Valley Hospital Fort Collins, Colorado
Sentara Martha Jefferson Hospital Charlottesville, Virginia
Sentara Norfolk General Hospital Norfolk, Virginia
UCHealth Greeley Hospital Greeley, Colorado Site Public Contact - (ctsucontact@westat.com)
UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina Site Public Contact - (cancerclinicaltrials@med.unc.edu)
University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma Site Public Contact - (ou-clinical-trials@ouhsc.edu)
VCU Community Memorial Health Center South Hill, Virginia Site Public Contact - (nemer.elmouallem@vcuhealth.org)
VCU Massey Cancer Center at Stony Point Richmond, Virginia Site Public Contact - (ctoclinops@vcu.edu)
VCU Massey Comprehensive Cancer Center Richmond, Virginia Site Public Contact - (CTOclinops@vcu.edu)
Washington University School of Medicine St Louis, Missouri Site Public Contact - (info@siteman.wustl.edu)

National Cancer Institute "Cancer Moonshot Biobank" (moonshot)

Castellanos, Natasha, Guzy - castellanosn@vcu.edu

Poklepovic, Andrew, S
NCT04314401
HM20020956
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Is consistent with OR has been diagnosed with one of the following: * Colorectal cancer: stage IV * Non-small cell or small cell lung cancer: stage III/IV * Prostate cancer: metastatic prostate cancer * Gastric cancer, not otherwise specified (NOS): stage IV * Esophageal cancer, NOS: stage IV * Adenocarcinoma of gastroesophageal junction: stage IV * High grade serous ovarian cancer: stage III/IV * Invasive breast carcinoma: stage III/IV * Melanoma: stage III/IV * Acute myeloid leukemia * Multiple myeloma * For the purposes of this study, * Re-staging is allowed * Having more than one primary cancer is allowed, if the patient is being treated solely for one of the eligible cancers listed above * Patient should fit in one of the following four clinical scenarios (a-d) * Undergoing diagnostic workup for one of the diseases listed for which treatment will likely include a new regimen of standard of care therapy OR * Scheduled to begin treatment with a new regimen of standard of care therapy OR * Currently progressing on a regimen of standard of care therapy OR * Currently being treated with a regimen standard of care therapy, without evidence of progression * Requirements for fresh tissue biospecimen collections at enrollment: * For clinical scenarios a, b, and c above, freshly collected tumor tissue or bone marrow (BM) aspirate must be submitted at enrollment * For clinical scenarios a and b, the fresh tissue collection must be prior to starting therapy * For clinical scenario a, the biospecimen collection must be part of a standard of care medical procedure * For clinical scenarios b or c, the biospecimen collection may be part of a standard of care medical procedure OR * The biospecimen collection may be part of a study-specific procedure ("research only biopsy"), when the patient has a tumor amenable to image guided or direct vision biopsy and is willing and able to undergo a tumor biopsy for molecular profiling * Note: For research-only biopsies, the biopsy must not be associated with a significant risk of severe or major complications or death; the procedure cannot be a mediastinal, laparoscopic, open or endoscopic biopsy; nor can the procedure be a brain biopsy; nor can the patient be under the age of majority as determined by each U.S. state * Requirements for archival tissue: * For clinical scenarios a and b above, archival tissue as outlined below must be submitted IF AVAILABLE * For clinical scenarios c and d above, archival tissue as outlined below is REQUIRED * Pre-existing archival material (formalin-fixed, paraffin-embedded \[FFPE\] block, BM aspirate, or unstained slides) that: * Contains the cancer type for which the participant is enrolled, and * Was collected no more than 5 years prior to initiation of therapy, and * Contains at least a surface area of 5 mm\^2 and optimal surface area of 25 mm\^2 or 3-5 mL cryopreserved bone marrow aspirate to yield 200 million bone marrow mononuclear cells, and * Contains at least 10% tumor content. 70% tumor content is optimal, and * No more than 1 line of standard of care systemic therapy was administered from the date of archival material collection to the date of initiation of therapy * Requirements for blood collection: ALL scenarios require fresh blood collection at enrollment * Blood collection for clinical scenarios a, b, and c must take place within 1 week of fresh tumor specimen collection * Blood collection for clinical scenario d must take place within 4 weeks of enrollment, and while patient is on treatment * Age 13 or older * Any sex * Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2 * Ability to understand and willingness to sign an informed consent document. Consent may be provided by a Legally Authorized Representative (LAR) in accordance with 45 CFR 46.102(i) * NCI PDMR INCLUSION CRITERIA: Patients with CRC with mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) status * NCI PDMR INCLUSION CRITERIA: Patients with CRC who are 40 years old or younger at time of collection irrespective of mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) status * NCI PDMR INCLUSION CRITERIA: Patients with BRCA that are either * Any race/ethnicity with hormone receptor positive (ER+PR+, ER+PR-, or ER-PR+) * African American with triple negative (ER-PR-HER2-) * NCI PDMR INCLUSION CRITERIA: Patients with lung cancer (LCA), prostate cancer (PCA), gastroesophageal cancer (GEC), ovarian cancer (OV), acute myeloid leukemia (AML), multiple myeloma (MML)
Exclusion Criteria:
* Treated with or has already begun treatment with a non-standard of care therapeutic agent (investigational) in an interventional clinical trial * For the purposes of this study, past enrollment in clinical trials whereby the patient was randomized and treated with standard-of-care anti-cancer treatment (chemotherapy regimen, surgery and radiation therapy) is allowed * Uncontrolled intercurrent illness that in the physician's assessment would pose undue risk for biopsy * Use of full dose coumarin-derivative anticoagulants such as warfarin are prohibited. Patients may be switched to low molecular weight (LMW) heparin at physician discretion * Low molecular weight (LMW) heparin is permitted for prophylactic or therapeutic use * Factor X inhibitors are permitted * Use of anti-platelet drugs are permitted * Stopping the anticoagulation treatment for biopsy, bone marrow aspirate, or resection should be per site standard operating procedure (SOP) * NCI PDMR EXCLUSION CRITERIA: Patients with complete response * NCI PDMR EXCLUSION CRITERIA: Patients with invasive fungal infections * NCI PDMR EXCLUSION CRITERIA: Patients with active and/or uncontrolled infections or who are still recovering from an infection * Actively febrile patients with uncertain etiology of febrile episode * All antibiotics for non-prophylactic treatment of infection should be completed at least 1 week (7 days) prior to collection * No recurrence of fever or other symptoms related to infection for at least 1 week (7 days) following completion of antibiotics * NCI PDMR EXCLUSION CRITERIA: Patients with human immunodeficiency virus (HIV), active or chronic hepatitis (i.e. quantifiable hepatitis B virus \[HBV\]-deoxyribonucleic acid \[DNA\] and/or positive hepatitis B surface antigen \[HbsAg\], quantifiable hepatitis C virus \[HCV\]-ribonucleic acid \[RNA\]) or known history of HBV/HCV without documented resolution
PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography, PROCEDURE: Magnetic Resonance Imaging, OTHER: Medical Chart Review, PROCEDURE: Paracentesis, PROCEDURE: Positron Emission Tomography
Acute Myeloid Leukemia, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Esophageal Carcinoma, Fallopian Tube Carcinoma, Gastric Carcinoma, Hormone Receptor-Positive Breast Carcinoma, Invasive Breast Carcinoma, Lung Non-Small Cell Carcinoma, Lung Small Cell Carcinoma, Malignant Solid Neoplasm, Melanoma, Metastatic Prostate Carcinoma, Multiple Myeloma, Ovarian Carcinoma, Ovarian High Grade Serous Adenocarcinoma, Primary Peritoneal Carcinoma, Stage III Fallopian Tube Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8, Triple-negative Breast Carcinoma
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 152 locations

Study Locations

Hide all locations
Location Contacts
AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California
Alliance for Childhood Diseases/Cure 4 the Kids Foundation Las Vegas, Nevada Site Public Contact - (research@sncrf.org)
Audie L Murphy VA Hospital San Antonio, Texas
Aurora Saint Luke's Medical Center Milwaukee, Wisconsin Site Public Contact - (ncorp@aurora.org)
Bayhealth Hospital Kent Campus Dover, Delaware Site Public Contact - (clinical_trials@bayhealth.org)
Bayhealth Hospital Sussex Campus Milford, Delaware Site Public Contact - (clinical_trials@bayhealth.org)
Blank Children's Hospital Des Moines, Iowa
Boca Raton Regional Hospital Boca Raton, Florida
Broward Health Medical Center Fort Lauderdale, Florida Site Public Contact - (Allison.bruce@nemours.org)
Broward Health North Deerfield Beach, Florida
Cancer Care Specialists of Illinois - Decatur Decatur, Illinois Site Public Contact - (morganthaler.jodi@mhsil.com)
Carle Cancer Center Urbana, Illinois Site Public Contact - (Research@carle.com)
Carle Physician Group-Mattoon/Charleston Mattoon, Illinois Site Public Contact - (Research@carle.com)
Carle at The Riverfront Danville, Illinois Site Public Contact - (Research@Carle.com)
Carson Tahoe Regional Medical Center Carson City, Nevada Site Public Contact - (research@sncrf.org)
Centra Alan B Pearson Regional Cancer Center Lynchburg, Virginia
Centro Comprensivo de Cancer de UPR San Juan, Site Public Contact - (ctsucontact@westat.com)
Chelsea Hospital Chelsea, Michigan Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Children's Hospital New Orleans New Orleans, Louisiana
Children's Hospital at Montefiore The Bronx, New York Site Public Contact - (aaraiza@montefiore.org)
Chilton Medical Center Pompton, New Jersey
Comprehensive Cancer Centers of Nevada Las Vegas, Nevada Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada - Central Valley Las Vegas, Nevada Site Public Contact - (research@sncrf.org)
Comprehensive Cancer Centers of Nevada - Town Center Las Vegas, Nevada Site Public Contact - (research@sncrf.org)
Corewell Health Grand Rapids Hospitals - Butterworth Hospital Grand Rapids, Michigan Site Public Contact - (crcwm-regulatory@crcwm.org)
CoxHealth South Hospital Springfield, Missouri
Decatur Memorial Hospital Decatur, Illinois Site Public Contact - (morganthaler.jodi@mhsil.com)
Dickinson County Healthcare System Iron Mountain, Michigan Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
ECU Health Medical Center Greenville, North Carolina Site Public Contact - (research@ecuhealth.org)
ECU Health Oncology Kinston Kinston, North Carolina Site Public Contact - (research@ecuhealth.org)
East Carolina University Greenville, North Carolina Site Public Contact - (eubankss@ecu.edu)
Edwards Comprehensive Cancer Center Huntington, West Virginia Site Public Contact - (Christina.Cole@chhi.org)
FirstHealth of the Carolinas-Moore Regional Hospital Pinehurst, North Carolina Site Public Contact - (jcwilliams@firsthealth.org)
Freeman Health System Joplin, Missouri Site Public Contact - (LJCrockett@freemanhealth.com)
Gibbs Cancer Center-Gaffney Gaffney, South Carolina Site Public Contact - (kmertz-rivera@gibbscc.org)
Gibbs Cancer Center-Pelham Greer, South Carolina Site Public Contact - (kmertz-rivera@gibbscc.org)
Good Samaritan Hospital - Cancer Centers of Colorado Lafayette, Colorado Site Public Contact - (peaksresearch@imail.org)
Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama Site Public Contact - (donna.goggins@infirmaryhealth.org)
Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama Site Public Contact - (donna.goggins@infirmaryhealth.org)
Harold Alfond Center for Cancer Care Augusta, Maine
Hartford Hospital Hartford, Connecticut
Heartland Regional Medical Center Saint Joseph, Missouri Site Public Contact - (Trisha.England2@mymlc.com)
Hope Cancer Care of Nevada Las Vegas, Nevada Site Public Contact - (research@sncrf.org)
Illinois CancerCare - Washington Washington, Illinois Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Bloomington Bloomington, Illinois Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Galesburg Galesburg, Illinois Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Pekin Pekin, Illinois Site Public Contact - (andersonj@illinoiscancercare.com)
Illinois CancerCare-Peoria Peoria, Illinois Site Public Contact - (andersonj@illinoiscancercare.com)
Intermountain Health Platte Valley Hospital Brighton, Colorado Site Public Contact - (peaksresearch@imail.org)
Iowa Methodist Medical Center Des Moines, Iowa
John H Stroger Jr Hospital of Cook County Chicago, Illinois
Kingman Regional Medical Center Kingman, Arizona Site Public Contact - (research@sncrf.org)
LSU Health Sciences Center at Shreveport Shreveport, Louisiana
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia Site Public Contact - (underberga@sjchs.org)
Lutheran Hospital - Cancer Centers of Colorado Golden, Colorado Site Public Contact - (peaksresearch@imail.org)
MMP Surgical Care Casco Bay Portland, Maine Site Public Contact - (ClinicalResearch@mmc.org)
Maine Children's Cancer Program Scarborough, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
Maine Medical Partners Neurology Scarborough, Maine Site Public Contact - (ClinicalResearch@mmc.org)
Maine Medical Partners Surgical Care Portland, Maine
MaineHealth Cancer Care and IV Therapy - Brunswick Brunswick, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
MaineHealth Cancer Care and IV Therapy - Sanford Sanford, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
MaineHealth Cancer Care and IV Therapy - South Portland South Portland, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
MaineHealth Franklin Hospital Farmington, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
MaineHealth LincolnHealth Hospital Damariscotta, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
MaineHealth Maine Medical Center - Biddeford Biddeford, Maine
MaineHealth Maine Medical Center - Portland Portland, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
MaineHealth Maine Medical Center- Scarborough Scarborough, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
MaineHealth Stephens Hospital Norway, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
MaineHealth Urology - South Portland South Portland, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
MaineHealth Waldo Hospital Belfast, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
Marion L Shepard Cancer Center - ECU Health Beaufort Hospital Washington, North Carolina Site Public Contact - (research@ecuhealth.org)
Marshfield Clinic - Wisconsin Rapids Center Wisconsin Rapids, Wisconsin Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Minocqua Minocqua, Wisconsin Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center - Weston Weston, Wisconsin Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-EC Cancer Center Eau Claire, Wisconsin Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Marshfield Marshfield, Wisconsin Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-Rice Lake Rice Lake, Wisconsin Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
Marshfield Medical Center-River Region at Stevens Point Stevens Point, Wisconsin Site Public Contact - (oncology.clinical.trials@marshfieldresearch.org)
McFarland Clinic - Ames Ames, Iowa Site Public Contact - (ksoder@mcfarlandclinic.com)
Mercy Clinic-Rolla-Cancer and Hematology Rolla, Missouri
Mercy Hospital Fort Smith Fort Smith, Arkansas
Mercy Hospital Joplin Joplin, Missouri Site Public Contact - (esmeralda.carrillo@mercy.net)
Mercy Hospital Oklahoma City Oklahoma City, Oklahoma
Mercy Hospital Saint Louis St Louis, Missouri
Mercy Hospital South St Louis, Missouri Site Public Contact - (Danielle.Werle@mercy.net)
Mercy Hospital Springfield Springfield, Missouri
Mercy Hospital Washington Washington, Missouri
Mercy Infusion Center - Chippewa St Louis, Missouri
Mercy Oncology and Hematology - Clayton-Clarkson Ballwin, Missouri
Mid Coast Hospital Brunswick, Maine Site Public Contact - (ctsucontact@westat.com)
Missouri Baptist Medical Center St Louis, Missouri
Mobile Infirmary Medical Center Mobile, Alabama
Monongalia Hospital Morgantown, West Virginia
Montefiore Medical Center - Moses Campus The Bronx, New York Site Public Contact - (eskwak@montefiore.org)
Montefiore Medical Center-Einstein Campus The Bronx, New York Site Public Contact - (eskwak@montefiore.org)
Montefiore Medical Center-Weiler Hospital The Bronx, New York Site Public Contact - (eskwak@montefiore.org)
Morristown Medical Center Morristown, New Jersey
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, New York Site Public Contact - (cancerclinicaltrials@cumc.columbia.edu)
Nebraska Cancer Specialists/Oncology Hematology West PC Grand Island, Nebraska
Newton Medical Center Newton, New Jersey
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital Yakima, Washington Site Public Contact - (Memorial-ClinicalTrials@yvmh.org)
NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois
NorthShore University HealthSystem-Glenbrook Hospital Glenview, Illinois
NorthShore University HealthSystem-Highland Park Hospital Highland Park, Illinois
Northside Hospital Atlanta, Georgia Site Public Contact - (ClinicalTrials@northside.com)
Novant Health Cancer Institute - Kernersville Kernersville, North Carolina Site Public Contact - (asmarrs@novanthealth.org)
Novant Health Cancer Institute - Mount Airy Mount Airy, North Carolina Site Public Contact - (asmarrs@novanthealth.org)
Novant Health Cancer Institute - Thomasville Thomasville, North Carolina Site Public Contact - (pjordan@novanthealth.org)
Novant Health Forsyth Medical Center Winston-Salem, North Carolina Site Public Contact - (pjordan@novanthealth.org)
Novant Health Presbyterian Medical Center Charlotte, North Carolina
Oncology Associates at Mercy Medical Center Cedar Rapids, Iowa
OptumCare Cancer Care at Charleston Las Vegas, Nevada Site Public Contact - (research@sncrf.org)
OptumCare Cancer Care at Fort Apache Las Vegas, Nevada Site Public Contact - (research@sncrf.org)
OptumCare Cancer Care at Seven Hills Henderson, Nevada Site Public Contact - (research@sncrf.org)
Our Lady of the Lake Physician Group Baton Rouge, Louisiana Site Public Contact - (research@ololrmc.com)
Overlook Hospital Summit, New Jersey
PCR Oncology Arroyo Grande, California Site Public Contact - (research@sncrf.org)
Penobscot Bay Medical Center Rockport, Maine Site Public Contact - (clinicalresearch@mainehealth.org)
Phelps Health Delbert Day Cancer Institute Rolla, Missouri Site Public Contact - (research@phelpshealth.org)
Physicians' Clinic of Iowa PC Cedar Rapids, Iowa
Prisma Health Baptist Hospital Columbia, South Carolina
Prisma Health Greenville Memorial Hospital Greenville, South Carolina Site Public Contact - (Kim.Williams3@prismahealth.org)
Prisma Health Richland Hospital Columbia, South Carolina Site Public Contact - (Kim.Williams3@prismahealth.org)
Roger Williams Medical Center Providence, Rhode Island Site Public Contact - (fdallesandro@chartercare.org)
SMC Center for Hematology Oncology Union Union, South Carolina Site Public Contact - (kmertz-rivera@gibbscc.org)
SSM Health Good Samaritan Mount Vernon, Illinois Site Public Contact - (gayla.hall@ssmhealth.com)
Saint James Community Hospital and Cancer Treatment Center Butte, Montana
Saint Joseph Hospital Lexington, Kentucky Site Public Contact - (carcieri@sjh-nh.org)
Saint Joseph Hospital - Cancer Centers of Colorado Denver, Colorado
Saint Mary's Hospital and Regional Medical Center Grand Junction, Colorado Site Public Contact - (ccrp@co-cancerresearch.org)
Saint Mary's Regional Medical Center Reno, Nevada
Saint Vincent Frontier Cancer Center Billings, Montana
Salinas Valley Memorial Salinas, California Site Public Contact - (tnielsen2@svmh.com)
San Juan City Hospital San Juan,
San Juan Community Oncology Group San Juan,
Spartanburg Medical Center Spartanburg, South Carolina Site Public Contact - (kmertz-rivera@gibbscc.org)
Swedish Covenant Hospital Chicago, Illinois
Tampa General Hospital Tampa, Florida Site Public Contact - (syapchanyk@tgh.org)
Thomas Hospital Fairhope, Alabama
Trinity Health Medical Center - Brighton Brighton, Michigan Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Medical Center - Canton Canton, Michigan Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Joseph Mercy Hospital Ann Arbor Ann Arbor, Michigan Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Joseph Mercy Oakland Hospital Pontiac, Michigan Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
Trinity Health Saint Mary Mercy Livonia Hospital Livonia, Michigan Site Public Contact - (MCRCwebsitecontactform@stjoeshealth.org)
UI Health Care Mission Cancer and Blood - Des Moines Clinic Des Moines, Iowa
University Medical Center New Orleans New Orleans, Louisiana Site Public Contact - (emede1@lsuhsc.edu)
University of Iowa Healthcare Cancer Services Quad Cities Bettendorf, Iowa Site Public Contact - (katherine-daprile@uiowa.edu)
University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa
VCU Massey Cancer Center at Stony Point Richmond, Virginia Site Public Contact - (ctoclinops@vcu.edu)
VCU Massey Comprehensive Cancer Center Richmond, Virginia Site Public Contact - (CTOclinops@vcu.edu)
Valley Medical Center Renton, Washington Site Public Contact - (research@valleymed.org)
Veterans Affairs Loma Linda Healthcare System Loma Linda, California